 |
|
SNM applauds House action to build medical isotopes reactor in the US
November 09, 2009American Medical Isotopes Production Act of 2009 will ensure reliable medical isotope supply
Reston, Va.-SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009.
"The worldwide isotope shortage has long been adversely affecting patients in the U.S.," said Michael M. Graham, Ph.D., M.D., president of SNM. "This important legislation will bring us one step closer to solving this chronic problem."
The American Medical Isotopes Production Act of 2009 was introduced by Congressman Edward J. Markey (D-MA) in July.
"Congressman Markey has worked closely with the medical community, members of industry and other stakeholders to ensure that this important legislation comes to fruition," said Robert W. Atcher, Ph.D., M.B.A., chair of SNM's Domestic Isotope Availability Taskforce. "The time is now to make sure that the U.S. has long-term access to medical isotopes-without having to rely on foreign producers."
Molybdenum-99 (Mo-99) is a critical medical isotope. Technetium-99m-the decay product of Mo-99-is used in more than 16 million diagnostic medical tests annually in the U.S. for the early detection and effective management of cancer, heart disease, thyroid disease and other serious conditions.
There are currently only six foreign producers of Mo-99 approved by the U.S. Food and Drug Administration to import the product into the U.S.-and no domestic facilities exist which are dedicated to the production of Mo-99 for medical uses. These aging foreign reactors regularly experience significant ongoing maintenance issues-frequently causing these reactors to go off-line. These continuing problems were exacerbated with reactors shutting down in Canada and the Netherlands earlier this year. Subsequently, the Canadian government announced that it will no longer produce medical isotopes as of 2016.
"To date, it has not been a pretty picture-and that is why SNM is so supportive of the House's approval of this bill," added Graham.
Most reactors in the world that produce Mo-99 utilize highly enriched uranium (HEU), which can also be used in the construction of nuclear weapons. Under this legislation, nuclear reactors that produce Mo-99 would have to stop using HEU and make the transition to low enriched uranium (LEU) as a replacement.
The American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval. If enacted, this legislation would create a stable and reliable supply of medical isotopes in the U.S.
"This is landmark legislation for patients and all Americans," said Graham.
Society of Nuclear Medicine
The American Medical Isotopes Production Act of 2009 was introduced by Congressman Edward J. Markey (D-MA) in July.
"Congressman Markey has worked closely with the medical community, members of industry and other stakeholders to ensure that this important legislation comes to fruition," said Robert W. Atcher, Ph.D., M.B.A., chair of SNM's Domestic Isotope Availability Taskforce. "The time is now to make sure that the U.S. has long-term access to medical isotopes-without having to rely on foreign producers."
Molybdenum-99 (Mo-99) is a critical medical isotope. Technetium-99m-the decay product of Mo-99-is used in more than 16 million diagnostic medical tests annually in the U.S. for the early detection and effective management of cancer, heart disease, thyroid disease and other serious conditions.
There are currently only six foreign producers of Mo-99 approved by the U.S. Food and Drug Administration to import the product into the U.S.-and no domestic facilities exist which are dedicated to the production of Mo-99 for medical uses. These aging foreign reactors regularly experience significant ongoing maintenance issues-frequently causing these reactors to go off-line. These continuing problems were exacerbated with reactors shutting down in Canada and the Netherlands earlier this year. Subsequently, the Canadian government announced that it will no longer produce medical isotopes as of 2016.
"To date, it has not been a pretty picture-and that is why SNM is so supportive of the House's approval of this bill," added Graham.
Most reactors in the world that produce Mo-99 utilize highly enriched uranium (HEU), which can also be used in the construction of nuclear weapons. Under this legislation, nuclear reactors that produce Mo-99 would have to stop using HEU and make the transition to low enriched uranium (LEU) as a replacement.
The American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval. If enacted, this legislation would create a stable and reliable supply of medical isotopes in the U.S.
"This is landmark legislation for patients and all Americans," said Graham.
Society of Nuclear Medicine
Patients will face delays in getting diagnostic scans due to severe shortage of imaging agents
A global shortage of medical isotopes* used in over 80% of routine diagnostic nuclear imaging procedures such as heart imaging, bone scans and some cancer detection procedures, will cause delays and cancellations to diagnostic examinations across the UK and Europe in the next few weeks.
More Medical Isotopes Current Events and Medical Isotopes News Articles
 |
Medical Isotope Production Without Highly Enriched Uranium by Committee on Medical Isotope Production Without Highly Enriched Uranium (Author), National Research Council (Author) This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than... |
 |
REDISHIP Supreme Air Isotope Bench Hoods, Kewaunee - Each - Model KS-20S5448 by Kewaunee Designed primarily for use with radiochemicals. Cove-cornered, seamless welded stainless steel construction allows for easy cleaning and decontamination. Complete with a Type 304 stainless steel liner, and baffles with upper, center, and lower exhaust slots. Baffles are designed to minimize turbulence and optimize containment. Interior hood lining and baffles are constructed of 16-gauge, Type 304 stainless steel. Hoods come complete with integral worktop and hemispherical cupsink. The seamless welded, 14-gauge, Type 304 stainless steel worktop is dished 1.27cm (1/2") to contain spillage and has an integrally welded, 12.7cm (5") diameter cupsink at the left rear. Furnished with a Type 304 stainless steel lower deflector vane; a counterbalanced, frameless sash of 0.6cm (1/4") laminated... |
|
Fears that little known medical isotope could fall into the wrong hands.(SECURITY BEAT): An article from: National Defense by Gale Reference Team (Author) This digital document is an article from National Defense, published by National Defense Industrial Association on November 1, 2008. The length of the article is 371 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Fears that little known medical isotope could fall into the wrong hands.(SECURITY BEAT) Author: Gale Reference Team Publication: National Defense (Magazine/Journal) Date: November 1, 2008 Publisher: National Defense Industrial Association Volume: 93 Issue: 660 Page: 14(1) Distributed by Gale, a part of Cengage... | |
 |
Isotope Production and Applications in the 21st Century: Proceedings of the Third International Conference on Isotopes Vancouver, Canada 6-10 September, 1999 by B. C.) International Conference on Isotopes 1999 (Vancouver (Author), Nigel R. Stevenson (Author), Nigel R. Stevenson (Editor), TRIUMF (Editor) The Third International Conference on Isotopes focused on the theme of "Isotope Production and Applications in the 21st Century", and included presentations by several experts in this field. The three central subjects - isotopes in medicine, industry and the environment - were supplemented by presentations on developments in isotope production and synthesis, research into radiopharmaceuticals, applications in agriculture, analytical applications, radiocarbon dating, AMS and PET. Various views on the future directions for producers and users of isotopes were considered too. |
|
Desperately seeking moly: unreliable supplies of feedstock for widely used medical imaging isotope prompt efforts to develop U.S. sources.(Cover story): An article from: Science News by Janet Raloff (Author) This digital document is an article from Science News, published by Science Service, Inc. on September 26, 2009. The length of the article is 3248 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Desperately seeking moly: unreliable supplies of feedstock for widely used medical imaging isotope prompt efforts to develop U.S. sources.(Cover story) Author: Janet Raloff Publication: Science News (Magazine/Journal) Date: September 26, 2009 Publisher: Science Service, Inc. Volume: 176 Issue: 7 Page: 16(5) Article Type: Cover story Distributed by Gale, a part of Cengage... | |
|
Safe Handling of Radioactive Isotopes in Medical Practice by Edith H. Quimby (Author) | |
 |
Isotopes for Medicine and the Life Sciences by Committee on Biomedical Isotopes (Author), Institute of Medicine (Author), S. James Adelstein (Editor), Frederick J. Manning (Editor) Harvard University, Boston, Massachusetts. Report of the Committee on Biomedical Isotopes, Division of Health Sciences Policy, Institute of Medicine. Studies the production and availability of isotopes, and the education and training of those who handle the flow from the source to laboratories and bedsides. |
 |
Nitrogen Isotope Techniques (Isotopic Techniques in Plant, Soil, and Aquatic Biology) (v. 1) by Roger Knowles (Editor), Henry Blackburn (Editor), Eldor A. Paul (Editor), Jerry Melillo (Editor) This book is the first laboratory manual to bring together basic procedures for measurement of stable and radioactive isotopes of nitrogen, with specific applications to plant, soil, and aquatic biology. This bench-top reference gives practical coverage of mass and emission spectrometry, nitrogen fixation, nitrification, and identification, organic nitrogen, and the radioactive isotope 13N. Methods are described so that researchers can adapt them, without the aid of outside references, to virtually any task they may encounter in investigations of nitrogen transformation processes. Key Features * Serves as a practical guide for nitrogen isotope techniques * Features studies of nitrogen transformations in terrestrial and aquatic... |
 |
Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis by Robert R. Wolfe (Author), David L. Chinkes (Author) Isotope Tracers in Metabolic Research Principles and Practice of Kinetic Analysis In the past few years, the number of applications of tracers for in vivo biomedical studies has greatly increased. New analytical tools at the genetic and protein levels have spurred this growth, opening the door for a deeper understanding of metabolic events. This in turn promises to yield significant advances in the understanding and treatment of human disease. Now fully revised and expanded, Isotope Tracers in Metabolic Research, Second Edition is the established definitive text on stable and radioactive isotope tracers. In unique, multidisciplinary fashion, it presents comprehensive coverage of new methodological, mathematical, and theoretical approaches. This new Second Edition... |
|
Stable Isotope Pharmaceuticals: For Clinical Research and Diagnosis (Drug Development and Evaluation, Vol. 18) by Peter Krumbiegel (Author) |
| © 2009 BrightSurf.com |